These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 14818665)

  • 21. [Panmyelophthisis in the course of neosalvarsan therapy of syphilis].
    GRUSZECKI L
    Pol Tyg Lek (Wars); 1950 Dec; 5(49-50):1719-23. PubMed ID: 14816136
    [No Abstract]   [Full Text] [Related]  

  • 22. [Case of syphilis resistant to novarsol and biochinol].
    MOREINIS IM; KURLAT MM
    Vestn Venerol Dermatol; 1952; 2():54. PubMed ID: 14931869
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hepatitis complicating syphilis and its treatment, with special reference to the sequelae].
    BENDA L; RISSEL E; THALER H
    Dtsch Arch Klin Med; 1950; 197(5):477-507. PubMed ID: 14802197
    [No Abstract]   [Full Text] [Related]  

  • 24. [Behavior of serum proteins and some liver function tests in syphilitics following intramuscular injection of aresenobenzol].
    GRANA A
    Rass Dermatol Sifilogr; 1950; 3(4):166-78. PubMed ID: 14828059
    [No Abstract]   [Full Text] [Related]  

  • 25. [Massive mixed treatment of syphilis with penicillin-bismuth-arsenobenzols].
    POPCHRISTOV ; GEORGHIEV G; LEVCOFF A
    Prophyl Antivenerienne; 1949 Aug; 21(8):361-9. PubMed ID: 15392062
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical evaluation of spirotrypan, a new arsenobenzol preparation].
    FOLSCH F; GLASER J; KRIEGK HJ
    Z Haut Geschlechtskr; 1951 Apr; 10(7):288-92. PubMed ID: 14836949
    [No Abstract]   [Full Text] [Related]  

  • 27. [The chemotherapeutic effects of certain oil-soluble organomercuric compounds, of ebesal and of spirotrypan on experimental syphilis in rabbits].
    SCHLOSSBERGER H; BRANDIS H
    Dermatol Wochenschr; 1953; 127(18):427-30. PubMed ID: 13067679
    [No Abstract]   [Full Text] [Related]  

  • 28. [Experience with the new antisyphilitic, neo-arsoluin (formerly arsaminol)].
    GARTMANN H
    Dtsch Gesundheitsw; 1950 Jul; 5(30):950-3. PubMed ID: 15435159
    [No Abstract]   [Full Text] [Related]  

  • 29. [Syphilis, salvarsan, jaundice; problem of jaundice in the treatment of syphilis].
    Izv Meditsinskite Inst Bulg Akad Naukite Sofia Otd Biol Meditsinski Nauki; 1951; 2-3():187-210. PubMed ID: 14917481
    [No Abstract]   [Full Text] [Related]  

  • 30. [Dangers of salvarsan therapy in pregnancy].
    MERTENS HG
    Klin Wochenschr; 1950 Apr; 28(15/16):273-6. PubMed ID: 15437769
    [No Abstract]   [Full Text] [Related]  

  • 31. [Histochemical data on novarsenol precipitation in primary syphiloma].
    ZHELTAKOV MM
    Vestn Venerol Dermatol; 1951; 1():28-30. PubMed ID: 14817933
    [No Abstract]   [Full Text] [Related]  

  • 32. Penicillin-arsenoxide-bismuth treatment of early syphilis; follow-up of patients treated in 1947 in Oslo Municipal Hospital.
    GUNDERSEN H
    Acta Derm Venereol; 1950; 30(5):442-4. PubMed ID: 14789416
    [No Abstract]   [Full Text] [Related]  

  • 33. [Spirotrypan therapy of congenital syphilis].
    LAWRENZ KH
    Kinderarztl Prax; 1954 Jun; 22(6):248-52. PubMed ID: 13222623
    [No Abstract]   [Full Text] [Related]  

  • 34. [Syphilis therapy with spirotrypan].
    SCHWARZKOPF K
    Z Haut Geschlechtskr; 1953 Feb; 14(3):87-9. PubMed ID: 13078900
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical results with neo-arsoluin in syphilis therapy].
    HOFER W
    Dtsch Gesundheitsw; 1951 Nov; 6(47):1343-7. PubMed ID: 12988630
    [No Abstract]   [Full Text] [Related]  

  • 36. [Specific leutic factors and drug toxicity factors (arsphenamines and bismuth) in their relation to esophageal functional disorders].
    BORASI G; PESCE G
    Minerva Otorinolaringol; 1952; 2(5):426-9. PubMed ID: 13025136
    [No Abstract]   [Full Text] [Related]  

  • 37. The treatment of syphilis in the salvarsan era.
    ROSEN I
    AMA Arch Derm; 1956 May; 73(5):476-9. PubMed ID: 13312640
    [No Abstract]   [Full Text] [Related]  

  • 38. [Experiences with the arsenobenzene preparation Spirotrypan (Hoechst) in syphilis].
    LEDIG R
    Dermatol Wochenschr; 1952; 125(21):481-5. PubMed ID: 14954735
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical and serological experiences in treatment of syphilis with spirotrypan].
    THELEN K
    Z Haut Geschlechtskr; 1953 Aug; 15(4):126-30. PubMed ID: 13103281
    [No Abstract]   [Full Text] [Related]  

  • 40. [Spirotrypan, a new arsenobenzol preparation in syphilis therapy].
    SIEBERT G
    Med Klin; 1953 Aug; 48(32):1158-9. PubMed ID: 13086419
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.